Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs Q32 Bio Inc. (QTTB)

Arcturus Therapeutics Holdings Inc. and Q32 Bio Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and Q32 Bio Inc. are of similar size ($266.0M and $263.5M). Arcturus Therapeutics Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 3.1×. Arcturus Therapeutics Holdings Inc. grew revenue faster over the last twelve months: −68.7% against −307.3%. Q32 Bio Inc. has the higher net margin (0.00% vs −285.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Q32 Bio Inc. leads on 12 and Arcturus Therapeutics Holdings Inc. on 2.

Valuation

Metric ARCT QTTB Biotechnology median
P/E n/m 3.07 10.60
P/S 9.60 n/m 9.40
P/B 1.74 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.02 (13.63) 9.02
Earnings yield (29.90%) 32.54% (32.88%)
Free cash flow yield (21.30%) (6.84%) (23.13%)

Profitability

Metric ARCT QTTB Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (311.22%) 0.00% 0.00%
Net margin (285.91%) 0.00% 0.00%
Free cash flow margin (204.48%) 0.00% 0.00%
Return on equity (44.37%) 72.14% (51.96%)
Return on assets (35.06%) 37.13% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARCT QTTB Biotechnology median
Revenue growth (TTM) (68.74%) (307.33%) 6.76%
EPS growth (last fiscal year) 20.00% 136.78% 29.88%
Revenue growth, 5-year CAGR 53.78% 100.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARCT QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.68 20.30 4.97
Net debt to EBITDA 3.15 (2.21) 1.01

Dividend

Metric ARCT QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARCT QTTB Biotechnology median
Market cap 266.04m 263.46m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack